TrialBMJ open gastroenterology2020

Prevention of hepatic encephalopathy by administration of rifaximin and lactulose in patients with liver cirrhosis undergoing placement of a transjugular intrahepatic portosystemic shunt (TIPS): a multicentre randomised, double blind, placebo controlled trial (PEARL trial).

K de Wit et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.